×

Fused-tricyclic inhibitors of KRAS and methods of use thereof

  • US 10,428,064 B2
  • Filed: 04/15/2016
  • Issued: 10/01/2019
  • Est. Priority Date: 04/15/2015
  • Status: Active Grant
First Claim
Patent Images

1. A compound having the following structure (I′

  • a);

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×